Goossens, Chloë,Langouche, Lies,Van Den Berghe, Greet,Vanhorebeek, Ilse
申请号:
AU2017381059
公开号:
AU2017381059A1
申请日:
2017.12.04
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
This invention relates generally to methods and compositions for the treatment or prevention of critical illness myopathy and critical illness polyneuropathy and of critical illness myopathy and critical illness polyneuropathy caused by critical illnesses including sepsis, severe sepsis, severe sepsis with septic shock, and particularly to the use of a combination of parenteral or enteral feeding with a 3-hydroxybutyrate.